This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Novmetapharma Co., Ltd.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Heonjong Lee: Innovator in Viral Infection Treatment
Introduction
Heonjong Lee is a notable inventor based in Incheon, South Korea. He has made significant contributions to the field of medical science, particularly in the treatment of viral infections. His innovative approach combines specific compounds to enhance therapeutic efficacy.
Latest Patents
Heonjong Lee holds a patent for "Compositions and methods for treating virus infection." This patent discloses compositions that contain a combination of zinc and a cyclo(His-Pro) in effective amounts. The composition is particularly relevant for treating viral infections, including SARS-CoV-2 infections in mammals. This advancement represents a promising avenue for addressing viral challenges in healthcare.
Career Highlights
Heonjong Lee is associated with Novmetapharma Co., Ltd., where he continues to develop and refine his innovative ideas. His work is characterized by a commitment to improving treatment options for viral infections, showcasing his dedication to public health.
Collaborations
Heonjong Lee collaborates with esteemed colleagues, including Hoe-Yune Jung and Dohyun Lee. Their combined expertise contributes to the advancement of research and development in the pharmaceutical field.
Conclusion
Heonjong Lee's contributions to the treatment of viral infections highlight his role as an influential inventor in the medical field. His innovative compositions and methods pave the way for potential breakthroughs in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile